³Ô¹ÏÍøÕ¾

Latest type 1 diabetes News | Page 2

Worried about getting a blood test? 5 tips to make them easier (and still accurate)
Deakin takes Pledge to end diabetes stigma and discrimination
Mater Researchers recognised at 2023 Mater People Awards
Maternity, diabetes and mental health boost in ³Ô¹ÏÍøÕ¾’s plan
Mater Researchers discover new link to pancreatic hormone in Type 1 diabetes
New form of fast-acting insulin added to PBS
Local health professionals benefit from one of the region’s largest Paediatric events
Mater Researcher conferred title of Emeritus Professor alongside Lifetime Achievement Award 
Labor’s cruel silence for diabetes community
Mater launches Australian-first model of care for diabetic pregnant mums
Long COVID symptoms can improve, but their resolution is slow and imperfect
Australians with diabetes are increasingly dying from conditions not usually linked to diabetes, like dementia
New Rockliff Government Cabinet
Diabetes nurse educators escalate protected industrial action over fair pay
Researchers look to arrest the development of Type 1 diabetes in children More children are getting Type 1 diabetes and Mater Researcher…
Autoimmunity art: Making science accessible for blind and low-vision audiences
Inquiry to hear from diabetes advocates and people with lived experience
Study shows reactivation of beta-like cells in the pancreas to produce insulin
Core genes for type 1 diabetes revealed
AstraZeneca announces agreement with Quell Therapeutics to develop, manufacture and commercialise engineered T-regulatory cell therapies for autoimmune diseases
Long COVID could be caused by the virus lingering in the body. Here’s what the science says
Tackling the rise of autoimmune diseases with genetically modified cell therapies
Trial of Android artificial pancreas system for adults with type 1 diabetes
Proto Axiom invests in University of Sydney spin-out, EndoAxiom
Spin-off developing oral insulin receives commercial backing
People Power – introducing WHO’s new “Intention to action” Series to enhance the meaningful engagement of people with lived experience
World-first childhood diabetes study extended
Funding success for technology to protect babies of pregnant mothers with type 1 diabetes
Smart nanotechnology for more accurate delivery of insulin
Government maintains access to fast acting insulin
Smart nanotechnology for more accurate delivery of insulin
Understanding the aggressive nature of young-onset type 2 diabetes
Rapid cognitive decline uncommon in ageing people with HIV on stable treatment: study
Could insulin come in pill? How molecule that mimics insulin may advance diabetes research
Discovery suggests new way to target mantle cell lymphoma
Game-changing biotech company coming soon to Springfield
100 years after insulin was first used, why isn’t New Zealand funding latest life-changing diabetes technology?
ATAGI recommendations on use of Pfizer Covid vaccine for children aged 6 months to 4 years
Government supporting Australians living with type 1 diabetes
Landmark study finds home screening test can help prevent type 1 diabetes
Centre of Excellence will revolutionise technology as we know it
ATAGI recommend Covid vaccination for some children aged 6 months to under 5 years
New study explains link between diabetes and UTIs
Calls for automated insulin delivery system to be funded
Immunocompromised children under 5 now eligible for Covid vaccine
Diabetes on rise & new treatment subsidies
RACGP: Let’s cut red tape and allow GPs to approve glucose monitors ASAP
Australia’s first national biotechnology incubator announces round one funding